TNF‐α, IL‐1β and IL‐6 are well known for having primary roles in the pathogenesis of inflammatory diseases like rheumatoid arthritis 20, while the use of TNF‐α inhibitors have demonstrated considerable effectiveness in the treatment of inflammatory diseases such as psoriasis and psoriatic arthritis 21. Here, IL1B is linked to psoriasis.